Platelet-Rich Plasma (PRP) is an emerging biological treatment option for musculoskeletal injuries. Although there is a growing body of evidence for this intervention, a consensus remains distant regarding preparation parameters, number of injections, postprocedural care, and value within the realm of alternative treatment options. This point-counterpoint column provides a balanced perspective on some of the more common points of contention surrounding the use of PRP.
© Copyright 2019 Strength and Conditioning Journal. National Strength & Conditioning Association. All rights reserved.